# Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet

> **NCT07251712** · PHASE1 · RECRUITING · sponsor: **Galmed Pharmaceuticals Ltd** · enrollment: 32 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Aramchol

## Key facts

- **NCT ID:** NCT07251712
- **Lead sponsor:** Galmed Pharmaceuticals Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07251712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07251712, "Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07251712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*